Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
The GlaxoSmithKline plc stock is trending slightly upwards today, with an increase of €0.090 (0.490%) compared to yesterday's price.
Currently there is a rather positive sentiment for GlaxoSmithKline plc with 5 Buy predictions and 1 Sell predictions.
As a result the target price of €20.00 shows a positive potential of 32.626% compared to the current price of €15.08 for GlaxoSmithKline plc.
You may not comment on this article as you either did not confirm your account yet or were blocked. If you think this is a mistake please contact us. Show more
GlaxoSmithKline plc (LSE/NYSE: GSK) announced the US Food and Drug Administration (FDA) has approved BLENREP (belantamab mafodotin-blmf) as a monotherapy treatment for adult patients with relapsed
Which stocks are most interesting to you?
Sharewise collects the stock predictions of private investors. Register for free and profit from the Wisdom of the Crowds. And tell us what you think about the stocks you are interested in!
Information about Cookies on sharewise.com
This page uses Cookies. For proper functioning of the page Cookies are needed. You agree to using Cookies by clicking "OK".
More infos can be found in our Privacy declaration.
If you disagree this service is only available in very limited ways.
